Amedeo's Top 20

Amedeo Smart

Independent Medical Education

10 April 2023

Multidisciplinary Journal Club

  1. Travis S, Silverberg MS, Danese S, Gionchetti P, et al.
    Vedolizumab for the Treatment of Chronic Pouchitis.
    N Engl J Med 2023;388:1191-1200.

  1. Matarese G.
    The link between obesity and autoimmunity.
    Science 2023;379:1298-1300.

  2. Morand EF, Vital EM, Petri M, van Vollenhoven R, et al.
    Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I).
    Lancet 2023.

  3. Plotkin SA.
    Can We Prevent Congenital Infection By Cytomegalovirus?
    Clin Infect Dis 2023.

  4. Liedtke C, Mazouni C, Hess KR, Andre F, et al.
    Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer.
    J Clin Oncol 2023;41:1809-1815.

  1. Fisher B, Bryant J, Wolmark N, Mamounas E, et al.
    Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
    J Clin Oncol 2023;41:1795-1808.

  2. Maspero M, Ali K, Cazzaniga B, Yilmaz S, et al.
    Acute rejection after liver transplantation with machine perfusion versus static cold storage: a systematic review and meta-analysis.
    Hepatology 2023.

  3. Stamm TA, Partheymuller J, Mosor E, Ritschl V, et al.
    Determinants of COVID-19 vaccine fatigue.
    Nat Med 2023.

  4. Boughey JC, Rosenkranz KM, Ballman KV, McCall L, et al.
    Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance).
    J Clin Oncol 2023.

  5. Ho A, Orton R, Tayler R, Asamaphan P, et al.
    Adeno-associated virus 2 infection in children with non-A-E hepatitis.
    Nature 2023.

  1. Squifflet P, Saad ED, Loibl S, van Mackelenbergh MT, et al.
    Re-Evaluation of Pathologic Complete Response as a Surrogate for Event-Free and Overall Survival in Human Epidermal Growth Factor Receptor 2-Positive, Early Breast Cancer Treated With Neoadjuvant Therapy Including Anti-Human Epidermal Growth F
    J Clin Oncol 2023.

  2. Wu Y, Verma V, Gay CM, Chen Y, et al.
    Neoadjuvant immunotherapy for advanced, resectable non-small cell lung cancer: A systematic review and meta-analysis.
    Cancer 2023.

  3. Fuchs A, Kuhl JT, Sigvardsen PE, Afzal S, et al.
    Subclinical Coronary Atherosclerosis and Risk for Myocardial Infarction in a Danish Cohort : A Prospective Observational Cohort Study.
    Ann Intern Med 2023.

  4. Perez Molina JA, Crespillo-Andujar C, Zamora J, Fernandez-Felix BM, et al.
    Contribution of low CD4 cell counts and high HIV viral load to the efficacy of preferred first-line antiretroviral regimens for treating HIV infection: A systematic review and meta-analysis.
    Clin Infect Dis 2023.

  5. Kim NE, Raghunathan RS, Hughes EG, Longstaff XR, et al.
    Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3.
    J Clin Endocrinol Metab 2023.

  1. Yim HJ, Kim TH, Suh SJ, Yim SY, et al.
    Response-Guided Therapy With Cefotaxime, Ceftriaxone, or Ciprofloxacin for Spontaneous Bacterial Peritonitis: A Randomized Trial: A Validation Study of 2021 AASLD Practice Guidance for SBP.
    Am J Gastroenterol 2023;118:654-663.

  2. Shahid M, Rawls A, Ramirez V, Ryman S, et al.
    Illusory Responses across the Lewy Body Disease Spectrum.
    Ann Neurol 2023;93:702-714.

  3. Alswailem M, Alghamdi B, Alotaibi A, Aljomiah A, et al.
    Molecular genetics of diffuse sclerosing papillary thyroid cancer.
    J Clin Endocrinol Metab 2023.

  4. Chaves N, Broekhuis JM, Fligor SC, Collins RA, et al.
    Delay in Surgery and Papillary Thyroid Cancer Survival in the United States: a SEER-Medicare Analysis.
    J Clin Endocrinol Metab 2023.

  5. Speers CW, Symmans WF, Barlow WE, Trevarton A, et al.
    Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial.
    J Clin Oncol 2023;41:1841-1848.


more..

Privacy Policy